期刊文献+

糖尿病视网膜病变的诊治进展 被引量:6

Advances in diabetic retinopathy diagnosis and management
下载PDF
导出
摘要 糖尿病视网膜病变(diabetic retinopathy,DR)是糖尿病(diabetes mellitus)的特异性微血管并发症,也是目前全球中老年人视力损害的主要病因[1]。随着糖尿病患病率逐年攀升,DR的患病率也在不断升高。这不仅严重降低了糖尿病患者的生存质量,也给公共卫生事业造成了巨大的经济负担。因此,早预防、早诊断、早治疗DR,正日渐成为目前糖尿病管理领域亟待解决的核心问题之一。
作者 闫莉 刘艳 周华 李洁 YAN Li;LIU Yan;ZHOU Hua
出处 《内科理论与实践》 2019年第3期149-153,共5页 Journal of Internal Medicine Concepts & Practice
  • 相关文献

参考文献2

二级参考文献38

  • 1Blindness caused by diabetes--Massachusetts, 1987-1994. MMWR Morb Mortal Wkly Rep, 1996, 45:937-941.
  • 2Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund J, Haffner S, Ham- man RF, Ikram MK, Kayama T, Klein BE, Klein R, Krishnaiah S, Mayurasakorn K, O'Hare JP, Orchard TJ, Porta M, Rema M, Roy MS, Sharma T, Shaw J, Taylor H, Tielsch JM, Varma R, Wang JJ, WangN, West S, Xu L, Yasuda M, Zhang X, Mitchell P, Wong TY; Me- ta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care, 2012, 35:556-564.
  • 3Xie X, Xu L, Yang H, Wang S, Jonas JB. Frequency of diabetic reti- nopathy in the adult population in China: the Beijing Eye Study 2001. Int Ophthalmol, 2009, 29:485-493.
  • 4Xu J, Wei WB, Yuan MX, Yuan SY, Wan G, Zheng YY, Li YB, Wang S, Xu L, Fu HJ, Zbu LX, Pu XL, Zhang JD, Du XP, Li YL, Ji Y, Gu XN, Li Y, Pan SF, Cui XL, Bai W, Chen YJ, Wang ZM, Zhu QS, Gao Y, Liu de Y, Ji YT, Yang Z, Jonas JB. Prevalence and risk factors for diabetic retinopathy: the Beijing Communities Diabetes Study 6. Retina, 2012, 32:322-329.
  • 5Wang FI-I, Liang YB, Zhang F, Wang JJ, Wei WB, Tao QS, Sun LP, Friedman DS, Wang NL, Wong TY. Prevalence of diabetic retinopa- tby in rural China: the Handan Eye Study. Ophthalmology, 2009, 116 461 467.
  • 6ACCORD Study Group; ACCORD Eye Study Group, Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM, Hubbard L, Esser BA, Lovato JF, Perdue LH, Goff DC Jr, Cushman WC, Ginsberg HN, Elam MB, Genuth S, Gerstein HC, Schubart U, Fine LJ. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med, 2010, 363:233-244.
  • 7Vekasi J, Koltai K, Gaal V, Toth A, Juricskay I, Kesmarky G. The effect of aspirin on hemorheological parameters of patients with dia- betic retinopathy. Clin Hemorheol Microcirc, 2008, 39:385-389.
  • 8Aiello LP, Vignati L, Sheetz MJ, Zhi X, Girach A, Davis MD, Wolka AM, Shahri N, Milton RC. Oral protein kinase c beta inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C beta Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C beta Inhibitor-Diabetic Retinopathy Study 2. Retina, 2011, 31: 2084-2094.
  • 9Wilkinson-Berka JL, Rana I, Armani R, Agrotis A. Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for ret- inopathy. Clin Sci (Lond), 2013, 124:597-615.
  • 10Tillin T, Orchard T, Malm A, Fuller J, Chaturvedi N. The role of an- tihypertensive therapy in reducing vascular complications of type 2 diabetes. Findings from the Diabetic REtinopathy Candesartan Tri- als-Protect 2 study. J Hypertens, 2011, 29:1457-1462.

共引文献140

同被引文献54

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部